Concepedia

Response and progression on midostaurin in advanced systemic mastocytosis: KIT D816V and other molecular markers

Mohamad Jawhar, Juliana Schwaab, Nicole Naumann, Hans‐Peter Horny, Karl Sotlar, Torsten Haferlach, Georgia Metzgeroth, Alice Fabarius, Peter Valent, Wolf‐Karsten Hofmann,

Blood · 2017 · 114 citations · 24 references

DOIFull text

Open access

Concepts

Abstract

associated with progression in 7 patients. In midostaurin-treated advSM patients, the complexity and dynamics of mutational profiles significantly affect response, progression, and prognosis.

References

24

Clinical and biological implications of driver mutations in myelodysplastic syndromes

Elli Papaemmanuil, Moritz Gerstung, Luca Malcovati et al. · Blood · 2013 · 1.8K citations

, , +16

Clonal Architecture of Secondary Acute Myeloid Leukemia

Matthew J. Walter, Dong Shen, Li Ding et al. · New England Journal of Medicine · 2012 · 771 citations · Full text

, , +15

Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis

Jason Gotlib, Hanneke C. Kluin‐Nelemans, Tracy I. George et al. · New England Journal of Medicine · 2016 · 478 citations · Full text

, , +16

Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I

Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib et al. · Haematologica · 2015 · 329 citations · Full text

, , +12

Inferring clonal evolution of tumors from single nucleotide somatic mutations

Wei Jiao, Shankar Vembu, Amit G. Deshwar et al. · BMC Bioinformatics · 2014 · 272 citations · Full text

, , +17